pentadecanoic acid has been researched along with sirolimus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schork, NJ; Venn-Watson, S | 1 |
1 other study(ies) available for pentadecanoic acid and sirolimus
| Article | Year |
|---|---|
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds.
Topics: Diabetes Mellitus, Type 2; Fatty Acids, Essential; Humans; Longevity; Sirolimus | 2023 |